DocuSign Inc
Change company Symbol lookup
Select an option...
DOCU DocuSign Inc
VHUB Vapor Hub International Inc
VMC Vulcan Materials Co
VLO Valero Energy Corp
VIAC ViacomCBS Inc
VFC VF Corp
VECO Veeco Instruments Inc
VALE Vale SA
V Visa Inc
UVV Universal Corp
Go

Information Technology : Software | Large Cap Growth
Company profile

DocuSign Inc offers DocuSign Agreement Cloud, a software suite for automating the agreement process. It includes DocuSign eSignature, an electronic signature solution that allows an agreement to be signed electronically on a variety of devices. The Agreement Cloud also includes several other applications for automating pre- and post-signature processes, such as automatically generating an agreement from data in other systems, supporting negotiation workflow, collecting payment after signatures, and using artificial intelligence (AI) to analyze a collection of agreements for risks and opportunities. The Agreement Cloud also includes hundreds of integrations to other systems, so agreement processes can integrate with other business processes and data. Its key Agreement Cloud products include DocuSign Contract Lifecycle Management (CLM), Intelligent Insights, Gen for Salesforce, Negotiate for Salesforce, Guided Forms, Click, Identify, Standards-Based Signatures, Payments and eNotary.

Price
Delayed
$273.13
Day's Change
12.52 (4.80%)
Bid
--
Ask
--
B/A Size
--
Day's High
275.84
Day's Low
261.19
Volume
(Average)

Today's volume of 3,833,927 shares is on pace to be in-line with DOCU's 10-day average volume of 5,708,439 shares.

3,833,927

UPDATE: U.S. cannabis producers are now favored by Wall Street analysts, who've soured on Canadian companies

11:21 am ET April 20, 2021 (MarketWatch)
Print

By Philip van Doorn

Volatility is a feature of the marijuana sector, where stock prices have pulled back. A new banking bill may give cannabis investors hope.

April 20 has become a day of celebration for people who support the full legalization of marijuana -- including for recreational use.

But there's no denying how volatile the cannabis sector can be for investors. Here's a six-month chart showing total returns for three actively managed exchange traded funds in the space through April 19:

Read:Cannabis-banking bill approved is by House (https://www.marketwatch.com/story/cannabis-banking-bill-approved-by-house-future-in-senate-uncertain-11618878433?mod=article_inline)

Those are eye-watering numbers for any investment in a six-month period. But they also point to wild volatility. All three hit their all-time intraday highs Feb. 10. Since then, the Amplify Seymour Cannabis ETF (CNBS) has dropped 35%, while the AdvisorShares Pure Cannabis ETF (YOLO) has fallen 34% and the AdvisorShares Pure US Cannabis ETF (MSOS) has given up 29%.

New banking bill passes House

A piece of supportive news came Monday night, as the the House approved a bill that would give cannabis businesses access to the U.S. banking system.

Before that, a lot of good news for the industry had been priced in. For example, the real legalization of marijuana in New York state March 30 -- recreational use is now allowed and the legislation doesn't hide behind flaccid "decriminalization" language -- hadn't reversed cannabis stocks' swoon.

A critical distinction that investors need to understand is that the five largest Canadian marijuana companies are publicly listed on U.S. exchanges, but the U.S. producers are listed only on Canadian exchanges. Shares of the U.S. multistate operators, known as MSOs, are available over-the-counter or on Canadian exchanges because marijuana for recreational use is still illegal on the U.S. federal level.

This means several of the best-known marijuana companies -- the Canadian ones -- cannot sell product in the U.S., while the MSOs have free rein only in the 16 states where recreational use has been legalized.

YOLO and MSOS have been able to get around that problem by holding total return swaps for the MSOs. And on April 20 -- yes, on 4/20, the international day of marijuana smoking -- Amplify ETFs announced that CNBS will now be able to purchase MSO total return swaps (https://www.globenewswire.com/news-release/2021/04/20/2213019/0/en/CNBS-Cannabis-ETF-Announces-Ability-to-Access-MSOs-via-Swaps.html) as well.

The "big four" MSOs are Curaleaf Holdings Inc. , Green Thumb Industries Inc. , Cresco Labs Inc. and Trulieve Cannabis Corp. .

You can see below how favorable the opinion of Wall Street analysts is for the MSOs, while the group has few "buy" ratings on the "big five" Canadian producers: Canopy Growth Corp. (WEED.T), Aphria Inc. (APHA.T), Tilray Inc. (TLRY), Cronos Group Inc. (CRON.T) and Aurora Cannabis Inc. .

Click here (https://www.marketwatch.com/story/if-you-want-to-get-rich-with-marijuana-stocks-you-need-to-know-the-crucial-difference-between-u-s-and-canadian-companies-11613658205) for a detailed description of the three ETFs and how they invest in U.S. and Canadian marijuana producers.

Analysts' opinions

Despite being kept off U.S. exchanges, MSOs have plenty of coverage among analysts working for brokerage companies. In order to look beyond the big four MSOs, Dan Ahrens, the portfolio manager for YOLO and MSOS, has supplied a list of six of "the current most significant ones."

One of those, TPCO Holding Corp. , is covered by only two analysts, so it isn't included in the following list, in which all companies are covered by at least five analysts.

Here's a summary of opinion among Wall Street analysts for nine MSOS:

The first screen includes only percentages of "buy" or equivalent ratings, because none of the analysts have "sell" or equivalent ratings on any of the listed MSOs. You can see that sentiment is strong for the U.S. producers.

The ratings roundup is much different for the big five Canadian producers:

Forward price-to-sales ratios are shown, rather than price-to-earnings, because companies at such an early growth stage don't focus on booking profits. For comparison, the forward price-to-sales ratio for the Nasdaq Composite Index is 4.2.

Click here (https://www.marketwatch.com/story/aphria-and-tilray-cannabis-merger-moves-a-step-closer-to-approval-11618594687) for an update on the proposed merger of Aphria Inc. and Tilray Inc.

Read:Why this cannabis giant is betting on Europe to build a war chest ahead of the U.S. legalization bonanza (https://www.marketwatch.com/story/why-this-cannabis-giant-is-betting-on-europe-to-build-a-war-chest-ahead-of-the-u-s-legalization-bonanza-11617990136)

-Philip van Doorn; 415-439-6400; AskNewswires@dowjones.com

	

(END) Dow Jones Newswires

April 20, 2021 11:21 ET (15:21 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.